New York-based Terran Biosciences inked a deal with Paris-based Sanofi for two late-stage central nervous system (CNS) assets. Terran plans to advance them for neurological and psychological indications.
NEW YORK, April 13, 2022 /PRNewswire/ Terran Biosciences ("Terran"), a biotech platform company dedicated to the development of transformational therapeutics for neurological and psychiatric
/PRNewswire/ Terran Biosciences ("Terran"), a biotech platform company dedicated to the development of transformational therapeutics for neurological and.
Terran Biosciences and Blumentech S L announce the acquisition of a patent portfolio covering the groundbreaking discoveries of prominent psychedelics researcher Dr Jordi Riba - PRN India News webindia123.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from webindia123.com Daily Mail and Mail on Sunday newspapers.